Management of pregnancy and delivery in women with inherited bleeding disorders

Seminars in Fetal and Neonatal Medicine

Volumn 16, Issue 6, 2011, Pages 311-317

  Peyvandi, Flora ^a   Bidlingmaier, Christoph ^b   Garagiola, Isabella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bleeding neonate; Inherited bleeding disorders; Pregnancy and delivery; Prenatal diagnosis; Therapeutic management

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

AFIBRINOGENEMIA; BLEEDING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CONGENITAL BLOOD CLOTTING DISORDER; COUNSELING; DELIVERY; DYSFIBRINOGENEMIA; ELECTROLYTE DISTURBANCE; FLUSHING; GASTROINTESTINAL DISEASE; GLANZMANN DISEASE; HEADACHE; HUMAN; HYPERTENSION; HYPOFIBRINOGENEMIA; HYPONATREMIA; HYPOTENSION; PRENATAL DIAGNOSIS; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SPONTANEOUS ABORTION; THROMBOCYTE TRANSFUSION; VON WILLEBRAND DISEASE; WATER RETENTION;

FEMALE; HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 80053582150     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2011.07.006     Document Type: Review

References (48)

1. Mannucci P.M., Duga S., Peyvandi F. Recessively inherited coagulation disorders. Blood 2004, 104:1243-1252.
2. Peyvandi F., Palla R., Menegatti M., Mannucci P.M. Introduction: rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Semin Thromb Hemost 2009, 35:349-355.
3. James A.H. Women and bleeding disorders. Haemophilia 2010, 16(Suppl. 5):160-167.
4. Bremme K.A. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003, 16:153-168.
5. Kadir R., Chi C., Bolton-Maggs P. Pregnancy and rare bleeding disorders. Haemophilia 2009, 15:990-1005.
6. Lo Y.M., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
7. Chi C., Lee C.A., Shiltagh N., et al. Pregnancy in carriers of haemophilia. Haemophilia 2008, 14:56-64.
8. Knol H.M., Voskuilen M.A., Holterman F., et al. Reproductive choices and obstetrical experience in Dutch carriers of haemophilia A and B. Haemophilia 2011, 17:233-236.
9. James A.H. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005, 11:295-307.
10. Kriplani A., Singh B.M., Sowbernika R., et al. Successful pregnancy outcome in Bernard-Soulier syndrome. J Obstet Gynaecol Res 2005, 31:52-56.
11. George J.N., Caen J.P., Nurden A.T. Glanzman's thrombasthenia: the spectrum of clinical disease. Blood 1990, 75:1383-1395.
12. Siboni S.M., Spreafico M., Calò L., et al. Gynaecological and obstetrical problems in women with different bleeding disorders. Haemophilia 2009, 15:1291-1299.
13. Kobayashi T., Kanayama N., Tokunaga N., et al. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol 2000, 109:364-366.
14. Kumar M., Mehta P. Congenital coagulopathies and pregnancy: report of four pregnancies in a factor X-deficient woman. Am J Hematol 1994, 46:241-244.
15. Catanzarite V.A., Novotny W.F., Cousins L.M., et al. Pregnancies in a patient with congenital absence of prothrombin activity: case report. Am J Perinatol 1997, 14:135-138.
16. Lak M., Peyvandi F., Mannucci P.M. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand's disease. Br J Haematol 2000, 111:1236-1339.
17. Hodivala-Dilke K.M., McHugh K.P., Tsakiris D.A., et al. β3-Integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999, 103:229-238.
18. Iwaki T., Sandoval-Cooper M.J., Paiva M., et al. Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol 2002, 160:1021-1034.
19. Haverkate F., Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995, 73:151-161.
20. Asahina T., Kobayashi T., Okada Y., et al. Studies on the role of adhesive proteins in maintaining pregnancy. Horm Res 1998, 50(Suppl. 2):37-45.
21. Ljung R.C. Intracranial haemorrhage in haemophilia A and B. Br J Haematol 2008, 140:378-384.
22. Ljung R.C. The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery. Haemophilia 2010, 16:415-419.
23. James A.H., Hoots K. The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery. Haemophilia 2010, 16:420-424.
24. Madan B., Street A.M. What is the optimal mode of delivery for the haemophilia carrier expecting an affected infant-vaginal delivery or caesarean delivery?. Haemophilia 2010, 16:425-426.
25. Kadir R.A., Economides D.L., Braithwaite J., Goldman E., Lee C.A. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997, 104:803-810.
26. Mannucci P.M. Treatment of von Willebrand's disease. N Engl J Med 2004, 351:683-694.
27. Pike G.N., Bolton-Maggs P.H.B. Factor deficiencies in pregnancy. Hematol Oncol Clin N Am 2011, 25:359-378.
28. Philipp C.S. Platelet disorders. Inherited bleeding disorders in women 2009, 65-69. Wiley-Blackwell, Oxford. C.A. Lee, R.A. Kadir, P.A. Koudies (Eds.).
29. Bolton-Maggs P.H., Perry D.J., Chalmers E.A., et al. The rare coagulation disorders - review with guidelines for management from the United Kingdom haemophilia centre doctors' organisation. Haemophilia 2004, 10:593-628.
30. Frenkel E., Duksin C., Herman A., Sherman D.J. Congenital hypofibrinogenemia in pregnancy: report of two cases and review of the literature. Obstet Gynecol Surv 2004, 59:775-779.
31. Dupuy E., Soria C., Molho P., et al. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res 2001, 102:211-219.
32. Robertson L.E., Wasserstrum N., Banez E., et al. Hereditary factor VII deficiency in pregnancy: peripartum treatment with factor VII concentrate. Am J Hematol 1992, 40:38-41.
33. Salomon O., Steinberg D.M., Tamarin I., et al. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinolysis 2005, 16:37-41.
34. Kobayashi T., Terao T., Kojima T., et al. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990, 29:235-238.
35. Asahina T., Kobayashi T., Takeuchi K., et al. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv 2007, 62:255-260.
36. Lillicrap D., Nair S.C., Srivastava A., Rodeghiero F., Pabinger I., Federici A.B. Laboratory issues in bleeding disorders. Haemophilia 2006, 12(Suppl. 3):68-75.
37. Bussel J. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009, 7(Suppl. 1):253-257.
38. Lak M., Keihani M., Elahi F., et al. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999, 107:204-206.
39. Lak M., Peyvandi F., Ali Sharifian A., Karimi K., Mannucci P.M. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003, 1:1852-1853.
40. Kenet G., Chan A.K., Soucie J.M., Kulkarni R. Bleeding disorders in neonates. Haemophilia 2010, 16(Suppl. 5):168-175.
41. Monagle P., Ignjatovic V., Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev 2010, 24:63-68.
42. Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Semin Perinatol 1997, 21:70-85.
43. Monagle P., Barnes C., Ignjatovic V., et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006, 95:362-372.
44. Klarmann D., Eggert C., Geisen C., et al. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents. Transfusion 2010, 50:1571-1580.
45. Lawrie A.S., Green L., Mackie I.J., Liesner R., Machin S.J., Peyvandi F. Factor XIII - an underdiagnosed deficiency - are we using the right assays?. J Thromb Haemost 2010, 8:2478-2482.
46. Strauss T., Levy-Shraga Y., Ravid B., et al. Clot formation of neonates tested by thromboelastography correlates with gestational age. Thromb Haemost 2010, 103:344-350.
47. Muntean W., Leschnik B., Baier K., Cvirn G., Gallistl S. in vivo thrombin generation in neonates. J Thromb Haemost 2004, 2:2071-2072.
48. Chalmers E.A. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004, 89:F475-F478.